BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 24212720)

  • 21. [Surgery of hepatobiliary tumors].
    Bork U; Koch M; Büchler MW; Weitz J
    Chirurg; 2010 Feb; 81(2):111-16. PubMed ID: 20076936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Past, Present, and Future Management of Localized Biliary Tract Malignancies.
    Li J; Rocha FG; Mayo SC
    Surg Oncol Clin N Am; 2023 Jan; 32(1):83-99. PubMed ID: 36410923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
    Kelly KJ; Dukleska K; Kuk D; Kingham TP; D'Angelica MI; DeMatteo RP; Allen PJ; Jarnagin WR; Fong Y
    Ann Surg Oncol; 2014 Mar; 21(3):979-85. PubMed ID: 24212720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
    Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
    World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
    Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
    Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological features of long-term survivors for advanced biliary tract cancer and impact of the number of lymph nodes involved.
    Kobayashi S; Nagano H; Marubashi S; Kawamoto K; Wada H; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M
    Int J Surg; 2013; 11(2):145-51. PubMed ID: 23298575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional lymphadenectomy for gallbladder cancer: rational extent, technical details, and patient outcomes.
    Shirai Y; Wakai T; Sakata J; Hatakeyama K
    World J Gastroenterol; 2012 Jun; 18(22):2775-83. PubMed ID: 22719185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes.
    Shirai Y; Sakata J; Wakai T; Ohashi T; Ajioka Y; Hatakeyama K
    World J Surg Oncol; 2012 May; 10():87. PubMed ID: 22594526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.
    Clark CJ; Wood-Wentz CM; Reid-Lombardo KM; Kendrick ML; Huebner M; Que FG
    HPB (Oxford); 2011 Sep; 13(9):612-20. PubMed ID: 21843261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases.
    Meng H; Wang X; Fong Y; Wang ZH; Wang Y; Zhang ZT
    Jpn J Clin Oncol; 2011 Aug; 41(8):992-8. PubMed ID: 21712255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
    Ito K; Ito H; Allen PJ; Gonen M; Klimstra D; D'Angelica MI; Fong Y; DeMatteo RP; Brennan MF; Blumgart LH; Jarnagin WR
    Ann Surg; 2010 Apr; 251(4):675-81. PubMed ID: 20224368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.
    DeOliveira ML; Cunningham SC; Cameron JL; Kamangar F; Winter JM; Lillemoe KD; Choti MA; Yeo CJ; Schulick RD
    Ann Surg; 2007 May; 245(5):755-62. PubMed ID: 17457168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
    Jarnagin WR; Fong Y; DeMatteo RP; Gonen M; Burke EC; Bodniewicz BS J; Youssef BA M; Klimstra D; Blumgart LH
    Ann Surg; 2001 Oct; 234(4):507-17; discussion 517-9. PubMed ID: 11573044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995.
    Donohue JH; Stewart AK; Menck HR
    Cancer; 1998 Dec; 83(12):2618-28. PubMed ID: 9874470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined pancreaticoduodenectomy and hepatectomy for patients with locally advanced gallbladder carcinoma: long term results.
    Shirai Y; Ohtani T; Tsukada K; Hatakeyama K
    Cancer; 1997 Nov; 80(10):1904-9. PubMed ID: 9366291
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.